FZAPX
Price
$103.31
Change
-$0.93 (-0.89%)
Updated
Jul 13 closing price
Net Assets
10.95B
VSMPX
Price
$337.67
Change
-$2.70 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

FZAPX vs VSMPX

FZAPX vs VSMPX Comparison Chart in %
View a ticker or compare two or three
VS
FZAPX vs. VSMPX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FZAPX is a Buy and VSMPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 2.3T vs. FZAPX (11B). VSMPX pays higher dividends than FZAPX: VSMPX (1.06) vs FZAPX (0.52). FZAPX was incepted earlier than VSMPX: FZAPX (13 years) vs VSMPX (11 years). FZAPX (0.42) is less costly to investors than VSMPX (0.02). FZAPX is a more actively managed with annual turnover of: 13.00 vs. VSMPX (3.00). FZAPX has a lower initial minimum investment than VSMPX: FZAPX (0) vs VSMPX (100000000). FZAPX annual gain was more profitable for investors over the last year : 25.67 vs. VSMPX (21.48). VSMPX (66.52) and FZAPX (64.41) have equivalent 5 years return.
FZAPXVSMPXFZAPX / VSMPX
Total Expense Ratio0.420.022,100%
Annual Report Gross Expense Ratio0.420.022,100%
Fund Existence13 years11 years-
Gain YTD16.92711.206151%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets11B2.3T0%
Annual Yield % from dividends0.521.0649%
Returns for 1 year25.6721.48120%
Returns for 3 years63.2867.0394%
Returns for 5 years64.4166.5297%
Returns for 10 years210.71239.4388%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGSNX21.35N/A
N/A
Vanguard Real Estate Index Institutional
PCAOX91.03N/A
N/A
Principal Capital Appreciation R3
GARIX23.88N/A
N/A
Gotham Absolute Return Institutional
RLAIX24.27N/A
N/A
T. Rowe Price Latin America I
MCYCX15.72-0.49
-3.02%
NYLI Candriam Emerging Markets Eq Cl C